Hampel H - Search Results

1

Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death.

Li R, Yang L, Lindholm K, Konishi Y, Yue X, Hampel H, Zhang D, Shen Y. Li R, et al. Among authors: hampel h. J Neurosci. 2004 Feb 18;24(7):1760-71. doi: 10.1523/JNEUROSCI.4580-03.2004. J Neurosci. 2004. PMID: 14973251 Free PMC article.

2

The temporal localization of frame-shift ubiquitin-B and amyloid precursor protein, and complement proteins in the brain of non-demented control patients with increasing Alzheimer's disease pathology.

Konishi Y, Beach T, Sue LI, Hampel H, Lindholm K, Shen Y. Konishi Y, et al. Among authors: hampel h. Neurosci Lett. 2003 Sep 4;348(1):46-50. doi: 10.1016/s0304-3940(03)00567-6. Neurosci Lett. 2003. PMID: 12893422

3

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.

Zhong Z, Ewers M, Teipel S, Bürger K, Wallin A, Blennow K, He P, McAllister C, Hampel H, Shen Y. Zhong Z, et al. Among authors: hampel h. Arch Gen Psychiatry. 2007 Jun;64(6):718-26. doi: 10.1001/archpsyc.64.6.718. Arch Gen Psychiatry. 2007. PMID: 17548753

4

Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.

Hampel H, Shen Y. Hampel H, et al. Scand J Clin Lab Invest. 2009;69(1):8-12. doi: 10.1080/00365510701864610. Scand J Clin Lab Invest. 2009. PMID: 18609117 Review.

5

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease.

Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H, Trojanowski JQ, Blennow K. Hampel H, et al. Exp Neurol. 2010 Jun;223(2):334-46. doi: 10.1016/j.expneurol.2009.09.024. Epub 2009 Oct 6. Exp Neurol. 2010. PMID: 19815015 Free PMC article. Review.

6

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Jiang H, Hampel H, Prvulovic D, Wallin A, Blennow K, Li R, Shen Y. Jiang H, et al. Among authors: hampel h. Mol Neurodegener. 2011 Oct 6;6:69. doi: 10.1186/1750-1326-6-69. Mol Neurodegener. 2011. PMID: 21978728 Free PMC article.

7

Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease.

Sun Q, Hampel H, Blennow K, Lista S, Levey A, Tang B, Li R, Shen Y. Sun Q, et al. Among authors: hampel h. J Alzheimers Dis. 2014;41(3):877-86. doi: 10.3233/JAD-140177. J Alzheimers Dis. 2014. PMID: 24685635 Free PMC article.

8

Increased levels of CSF phosphorylated tau in apolipoprotein E epsilon4 carriers with mild cognitive impairment.

Buerger K, Teipel SJ, Zinkowski R, Sunderland T, Andreasen N, Blennow K, Ewers M, DeBernardis J, Shen Y, Kerkman D, Du Y, Hampel H. Buerger K, et al. Among authors: hampel h. Neurosci Lett. 2005 Dec 31;391(1-2):48-50. doi: 10.1016/j.neulet.2005.08.030. Epub 2005 Sep 13. Neurosci Lett. 2005. PMID: 16165272 Clinical Trial.

9

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.

Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H. Ewers M, et al. Among authors: hampel h. Brain. 2008 May;131(Pt 5):1252-8. doi: 10.1093/brain/awn034. Epub 2008 Mar 11. Brain. 2008. PMID: 18334538

10

Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer's disease.

Ewers M, Cheng X, Zhong Z, Nural HF, Walsh C, Meindl T, Teipel SJ, Buerger K, He P, Shen Y, Hampel H. Ewers M, et al. Among authors: hampel h. J Alzheimers Dis. 2011;25(2):373-81. doi: 10.3233/JAD-2011-091153. J Alzheimers Dis. 2011. PMID: 21460439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

889 results

Search Page

Filters